Adenocarcinoma of Lung, Stage IV Terminated Phase 3 Trials for Cetuximab (DB00002)

Also known as: Adenocarcinoma of Lung Stage IV / Lung adenocarcinoma stage IV / Adenocarcinoma Lung Stage IV / Stage IV Lung Adenocarcinoma / Lung adenocarcinoma metastatic / Adenocarcinoma of lung, stage IV (disorder)

IndicationStatusPhase
DBCOND0087327 (Adenocarcinoma of Lung, Stage IV)Terminated3
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00946712S0819: Carboplatin and Paclitaxel With or Without Bevacizumab and/or Cetuximab in Treating Patients With Stage IV or Recurrent Non-Small Cell Lung CancerTreatment